徐州四维彩超都能检查出什么徐州四维彩超如何看胎儿,徐州做四维家人可以进去吗,徐州做四维检查都查些什么,徐州上环哪种环比较好,徐州比较好的四维医院,徐州四维彩超检查多少费用,徐州孕21周四维b超

BEIJING, June 12 (Xinhua) -- China's Supreme People's Court (SPC) on Sunday publicized a judicial interpretation which sets specific rules for the country's courts to order penalties to criminals sabotaging TV and radio facilities.The interpretation said that criminals, whose sabotage causes information block for disaster early warning, rescue and others concern public security, could be convicted three to seven years of imprisonment on the charge of sabotaging TV and radio broadcast facilities.Other circumstances that could be convicted the imprisonment include sabotage that causes malfunction in the broadcast of TV and radio stations, according to the new law.According to statistics with the SPC, there have been more than 5,000 cases of sabotaging cable TV wires and more than 1,000 cases of sabotaging state-owned fiber optic lines and other cases of stealing broadcast facilities since 2006 in China.

BEIJING, July 22 (Xinhuanet) -- Regulation is needed to govern rapidly expanding research in animals containing human tissue or genes, according to the Britain's Academy of Medical Sciences.Using animals with limited humanized traits is not new. Genetically engineered mice containing human DNA are already a mainstay of research into new drugs for diseases like cancer.For instance, Chinese scientists have already introduced human stem cells into goat fetuses and U.S. researchers have studied the idea of creating a mouse with human brain cells.But Martin Bobrow, a professor of medical genetics at the University of Cambridge, who led the Academy's working group, said there were three areas of particular concern."Where people begin to worry is when you get to the brain, to the germ cells, and to the sort of central features that help us recognize what is a person, like skin texture, facial shape and speech," he said.His report recommends that government should put in place a national expert body, working within the existing system for regulating animal research, to oversee such sensitive areas.British ministers said they welcomed the report and would consider its recommendations carefully.

SAN FRANCISCO, June 15 (Xinhua) -- Facebook has hired Joe Lockhart, who was former U.S. President Bill Clinton's press secretary during the last two years of his second term, as the social network company's vice president of global communications, U.S. media reported on Wednesday.Lockhart, 51, will report to Elliot Schrage, Facebook's current vice president of global communications, marketing and public policy, The Wall Street Journal said in a report."His experience building and running a press office at the White House gives him particular appreciation for the demands of a global 24-hour news cycle and the challenges of responding effectively to intense scrutiny," Schrage said of Lockhart's arrival.Lockhart will start at Facebook on July 15 and will move from Washington D.C. to Facebook's headquarters in California.Lockhart is the latest Washington insider to join Facebook as the world's largest social networking site is facing intense scrutiny for its privacy practices and growing global presence, The Wall Street Journal pointed out.Last year, Facebook also hired White House economic adviser Marne Levine to serve as its vice president of global public policy.More recently, Facebook hired former Bush administration officials Joel Kaplan as its vice president for U.S. public policy, and Myriah Jordan, who will become a policy manager focusing on congressional relations.

WELLINGTON, June 7 (Xinhua) -- Scientists in New Zealand have developed a new drug to fight previously untreatable hypoxic cancer tumors, which form in areas of the body starved of oxygen.The researchers at the Auckland University have entered an agreement for the clinical development of CEN-209, which was developed over 10 years of research, said a statement from the university Tuesday.CEN-209 was designed to enhance the effectiveness of radiotherapy and chemotherapy in solid hypoxic tumors, which were resistant to standard cancer therapies, said the statement. In lung cancer patients for example, about half of tumors had hypoxic regions.The new drug worked by damaging the DNA of hypoxic cancer cells, while leaving normal, healthy tissues alone.CEN-209 was designed and created by researchers at the university's Auckland Cancer Society Research Centre (ACSRC), using computer models of drug transport within tumors to accurately predict the anti-tumor activity of the drugs."Our computer models of drug transport developed in-house allowed the synthetic chemists to test their design theories and considerably shortened the discovery process," said Associate Professor Michael Hay, who led the ACSRC research chemists."CEN-209 improves markedly on previous agents in this class in terms of its ability to penetrate tumors, and this is reflected by its improved activity in the laboratory, when combined with long or short courses of radiotherapy," said researcher Professor Bill Wilson.Under the agreement between the university's Auckland UniServices Ltd. and California-based Centella Therapeutics, Inc., a subsidiary of Varian Medical Systems, Inc., Centella will have exclusive rights to CEN-209, which it will develop and trial with Cancer Research UK.The work on CEN-209 is the culmination of a program initiated with funding from the U.S. National Cancer Institute, and more recently from the Maurice Wilkins Centre for Biodiscovery. Ongoing preclinical research on CEN-209 and a backup compound was funded by grants from the Auckland Medical Research Foundation, Genesis Oncology Trust and Health Research Council of New Zealand, said the statement.

WASHINGTON, July 5 (Xinhua) -- Adhering to a healthy lifestyle, including not smoking, exercising regularly, having a low body weight and eating a healthy diet, appears to lower the risk of sudden cardiac death (SCD) in women, according to a study to be published Wednesday in the Journal of the American Medical Association."Sudden cardiac death (defined as death occurring within one hour after symptom onset without evidence of circulatory collapse) accounts for more than half of all cardiac deaths, with an incidence of approximately 250,000 to 310,000 cases annually in the United States," the authors write as background information in the study.Using data collected as part of the Nurses' Health Study, Stephanie Chiuve, of Brigham and Women's Hospital and Harvard Medical School, and colleagues examined the association between a healthy lifestyle and risk of SCD.A total of 81,722 women who participated in the Nurses' Health Study from June 1984 to June 2010 were included in the new study, and lifestyle factors were assessed via questionnaires every two to four years. A low-risk lifestyle was defined as not smoking, having a body mass index (BMI) of less than 25, exercise duration of 30 minutes/day or longer, and consuming a diet closely related to a Mediterranean-style diet (emphasizes high intake of vegetables, fruits, nuts, legumes, whole grains and fish, with moderate alcohol intake).During the 26 years of follow-up, there were 321 cases of SCD among women (average age 72 years at the time of the SCD event) in the study. All four low-risk factors were significantly and independently associated with a lower risk of SCD. Not smoking, exercising and eating a healthy diet each were inversely associated with risk of SCD. BMI also was associated with the risk of SCD, with women having a BMI between 21 and 24.9 at lowest risk.Women at low risk for all four lifestyle factors had a 92 percent lower risk of SCD when compared with women at low risk for none of the four lifestyle factors."In this cohort of female nurses, adherence to an overall healthy lifestyle was associated with a lower risk of SCD and may be an effective strategy for the prevention of SCD," the authors write.